Both Semaglutide and copyright belong to a class of therapies called GLP-One receptor stimulators. These important medicines work by imitating the body's own hormone , GLP-One , to support lower glucose levels and encourage weight reduction . This common mechanism of effect demonstrates why they drugs are often considered together and represent a n